People With Severe Mental Illness Experienced Increased COVID-19 Mortality

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 21, 2023 -- People living with severe mental illness (SMI) experienced substantial inequalities in mortality outcomes during the COVID-19 pandemic, according to a study published in the November issue of the British Journal of Psychiatry.

Jayati Das-Munshi, Ph.D., from King's College London, and colleagues examined associations between COVID-19 and death in people with SMI (February 2020 to April 2021). The analysis included 7,146 individuals with SMI and 653,024 primary care patients without SMI.

The researchers found that following COVID-19 infection, the SMI group experienced a greater risk for death compared with controls (adjusted hazard ratio, 1.53). Death from COVID-19 was more likely among Black Caribbean/Black African people than White people (adjusted hazard ratio, 1.22), with similar associations seen in the SMI group and non-SMI group. For every additional multimorbidity condition, the adjusted hazard ratios for death following COVID-19 infection were 1.06 in the SMI group and 1.16 in the non-SMI group.

"These are stark findings and highlight the health inequalities that exist for people living with severe mental illness, people from racialized groups, and people from different regions of the country," Das-Munshi said in a statement. "The pandemic shone a light on these inequalities, and we must learn from this to develop new policies and improve service provision."

One author disclosed financial ties to Janssen, GSK, and Takeda.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-22 08:51

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords